Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.
Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.
复制标题
DOI:
10.1002/art.40438
复制
发表时间:
2018-06
期刊:
影响因子:
--
通讯作者:
Grom AA
中科院分区:
文献类型:
--
作者:
Schulert GS;Zhang M;Husami A;Fall N;Brunner H;Zhang K;Cron RQ;Grom AA
Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile idiopathic arthritis (SJIA), and has pathologic similarity to hemophagocytic lymphohistiocytosis (HLH). Intronic variants in UNC13D are found in patients with familial HLH-3 (FHL3), but the role of non-coding variants in MAS is unknown. The objective of this study was to identify deep intronic UNC13D variants in patients with MAS. A custom enrichment library was constructed to sequence approximately 1 MB flanking UNC13D in 24 patients with SJIA, recurrent MAS, and negative prior genetic (exon/coding) testing. Functional consequences of intronic variants were assessed using quantitative PCR on patient derived peripheral blood mononuclear cells (PBMC), electrophoretic mobility shift assay (EMSA), in vitro transcriptional enhancer assays, and NK cell degranulation assays. We report a patient with SJIA and recurrent MAS, found to have a novel functional intronic variant in UNC13D, c.117+143A>G. This variant occurs in a proposed regulatory region that drives lymphocyte specific UNC13D expression, and is associated with reduced transcript levels in patient PBMC. The patient’s variant also disrupts NFκB binding to a functional transcriptional enhancer, leading to reduced enhancer activity in vitro. Partial knockdown of UNC13D expression also led to impaired NK cell degranulation. An additional patient was identified with a previously described UNC13D intronic variant, for a total non-coding variant hit rate of 8.3% (2/24). These findings highlight that intronic variants in key regulatory regions may be associated with MAS in patients with SJIA, and support deep sequencing approaches when causative coding variants are not identified.
登录
查看更多内容
影响因子:
20.3
作者:
Meeths, Marie;Chiang, Samuel C. C.;Bryceson, Yenan T.
通讯作者:
Bryceson, Yenan T.
影响因子:
5.5
作者:
Vastert, Sebastiaan J.;van Wijk, Richard;Kuis, Wietse
通讯作者:
Kuis, Wietse
DOI:
10.4049/jimmunol.1501284
发表时间:
2016-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Zhang M;Bracaglia C;Prencipe G;Bemrich-Stolz CJ;Beukelman T;Dimmitt RA;Chatham WW;Zhang K;Li H;Walter MR;De Benedetti F;Grom AA;Cron RQ
通讯作者:
Cron RQ
影响因子:
13.3
作者:
Ravelli, Angelo;Minoia, Francesca;Cron, Randy Q.
通讯作者:
Cron, Randy Q.
DOI:
10.4049/jimmunol.1103129
发表时间:
2012-09-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Zhang M;Clausell A;Robinson T;Yin J;Chen E;Johnson L;Weiss G;Sabbaj S;Lowe RM;Wagner FH;Goepfert PA;Kutsch O;Cron RQ
通讯作者:
Cron RQ